We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information on isopropanol for use in responding to chemical incidents.
Information on public health microbiology services, provided by the London public health laboratory.
Information on magnesium, for use in responding to chemical incidents.
Advice on symptoms, diagnosis, complications and treatment of measles.
Detailed information to help parents protect their babies against meningitis and septicaemia caused by meningococcal group B (MenB).
Information and infographics with advice for people travelling to the Middle East from the UK, including translated versions.
Newborn blood spot (NBS) screening guidance for babies under a year of age with no available screening results.
The Advisory Council on the Misuse of Drugs has undertaken a review of naloxone's availability.
The National Mycobacterium Reference Service (NMRS) Central and North public health laboratory provides mycobacterial reference services.
An overview of the newborn and infant physical examination screening end-to-end pathway.
This document describes the newborn blood spot (NBS) screening pathway.
An overview of the newborn blood spot screening end-to-end pathway.
Evidence-based principles for the effective use of screening appointment text message reminders in reducing inequalities and supporting informed choice.
This document sets out the roles and contact details for the 4 regional quality assurance teams for NHS population screening in England.
Information to raise awareness with commissioners and providers of the community pharmacy offer for sexual health, reproductive health and HIV services.
Progress update on the PHE reproductive health programme, including a new return on investment tool and the next steps for 2021 to 2022.
Information for commissioners and screening providers, to help improve access to screening for people with severe mental illness.
Information on providing postural care support and reasonable adjustments to meet the needs of people with learning disabilities.
A resource to help local areas establish prevention planning arrangements to improve the public’s mental health.
NHS prostate cancer risk management programme (PCRMP) guidance on performing an ultrasound-guided prostate biopsy.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).